CYBN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 geg. 2024 @ 23:00):

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation...

Stats
Dzisiejszy wolumen	1.50M
Średni wolumen	5.29M
Kapitalizacja rynkowa	283.97M
EPS	$0 ( 2024-02-13 )
Następna data zysków	( $-0.0300 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.700
ATR14	$0.00200 (0.54%)

Wolumen Korelacja

Długi: -0.25 (neutral)

Krótki: 0.73 (moderate)

Signal:(41.614) Neutral

Cybin Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cybin Inc. Korelacja - Waluta/Towar

0.00
( neutral )

-0.42
( neutral )

Cybin Inc. Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$-251 000 (0.00 %)
EPS:	$-0.220

FY	2022
Przychody:	$0
Zysk brutto:	$-251 000 (0.00 %)
EPS:	$-0.220

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-0.430

FY	2021
Przychody:	$864 000
Zysk brutto:	$200 000 (23.15 %)
EPS:	$-0.320

Financial Reports:

No articles found.

Cybin Inc.